SCHEMBL1396785

SCHEMBL1396785

COc1ccc2c(Oc3ccc(N(C(=O)c4cc(-c5cccnc5)c[nH]c4=O)c4ccccc4)nc3)ccnc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTK2B Q14289 4/20 0.54
▸ MET P08581 15/20 0.48
▸ KDR P35968 14/20 0.48
▸ IGF1R P08069 13/20 0.48
▸ AURKA O14965 3/20 0.41
▸ TEK Q02763 3/20 0.41
▸ AURKB Q96GD4 2/20 0.41
▸ PDGFRA P16234 1/20 0.39
▸ JAK2 O60674 1/20 0.38
▸ RPS6KA5 O75582 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ INSR P06213 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ FES P07332 1/20 0.38
▸ CSF1R P07333 1/20 0.38
▸ LYN P07948 1/20 0.38
▸ RET P07949 1/20 0.38
▸ FGR P09769 1/20 0.38
▸ KIT P10721 1/20 0.38
▸ PIM1 P11309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1396735 0.93 PTK2B (0.54) PTK2BMETKDRPDGFRAKIT
SCHEMBL1396795 0.91 PTK2B (0.54) PTK2BMETKDRIGF1RAURKA
SCHEMBL1396757 0.83 PTK2B (0.46) PTK2BMETKDRPDGFRAKIT
SCHEMBL1396842 0.82 PTK2B (0.52) PTK2BMETKDRPDGFRA
SCHEMBL1396685 0.80 PTK2B (0.55) PTK2BMETKDRPDGFRAKIT
SCHEMBL1396736 0.78 PTK2B (0.53) PTK2BMETKDRPDGFRAKIT
SCHEMBL1396864 0.75 PTK2B (0.57) PTK2BMETKDRIGF1RAURKA
SCHEMBL1396738 0.73 MET (0.48) PTK2BMETKDRIGF1RPDGFRA
SCHEMBL1396822 0.71 MET (0.49) PTK2BMETKDRPDGFRAKIT
SCHEMBL1396814 0.71 PTK2B (0.53) PTK2BMETKDRIGF1RPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881976-A1 SUBSTITUTED AMIDE DERIVATIVES AS PROTEIN KINASE INHIBITORS Amgen Inc., (US) 2008-01-30 — — EP claimed
WO-2006116713-A1 SUBSTITUTED AMIDE DERIVATIVES AS PROTEIN KINASE INHIBITORS AMGEN INC. (US) 2006-11-02 — — WO claimed
EP-2288383-A1 COMBINATIONS VEGF(R) INHIBITORS AND HEPATOCYTE GROWTH FACTOR (C-MET) INHIBITORS FOR THE TREATMENT OF CANCER Amgen, Inc (US) 2011-03-02 — — EP disclosed
WO-2009140549-A1 COMBINATIONS VEGF(R) INHIBITORS AND HEPATOCYTE GROWTH FACTOR (C-MET) INHIBITORS FOR THE TREATMENT OF CANCER AMGEN INC. (US) 2009-11-19 — — WO disclosed
EP-1881976-A1 SUBSTITUTED AMIDE DERIVATIVES AS PROTEIN KINASE INHIBITORS Amgen Inc., (US) 2008-01-30 — — EP disclosed
WO-2006116713-A1 SUBSTITUTED AMIDE DERIVATIVES AS PROTEIN KINASE INHIBITORS AMGEN INC. (US) 2006-11-02 — — WO disclosed
Send feedback